The Australian company Mesoblast begins clinical trials of angiogenesis stimulation technology in the heart by introducing "adult" bone marrow stem cells
- Authors: Likhachev D.
- Issue: Vol 1, No 2 (2006)
- Pages: 27-27
- Section: Cell technology
- Submitted: 10.02.2023
- Accepted: 10.02.2023
- Published: 15.02.2006
- URL: https://genescells.ru/2313-1829/article/view/217684
- DOI: https://doi.org/10.23868/gc217684
- ID: 217684
Cite item
Full Text
About the authors
D. Likhachev
Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation